Effects of Various Methods of Holding Intramuscular Injection Sites in the Deltoid Region on Subcutaneous Tissue and Muscle Thickness
Not Applicable
- Conditions
- Healthy Japanese subjects
- Registration Number
- JPRN-UMIN000048289
- Lead Sponsor
- Tokyo Metropolitan University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Subjects who have deltoid muscle disease in either shoulder 2. Subjects with skin abnormalities in the deltoid muscle of either shoulder
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Thickness of subcutaneous tissue and muscle (ultrasound imaging)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How do deltoid injection site holding techniques affect subcutaneous tissue and muscle thickness in healthy Japanese subjects?
What is the comparative effectiveness of various deltoid injection site holding methods on tissue and muscle thickness in clinical practice?
Are there biomarkers that predict changes in deltoid muscle thickness following different injection site holding techniques?
What adverse events are associated with deltoid injection site holding methods, and how are they managed in clinical trials?
How do alternative deltoid injection techniques influence drug absorption and muscle tissue response in intramuscular administration?